242 related articles for article (PubMed ID: 32798703)
1. Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study.
Greuter T; Godat A; Ringel A; Almonte HS; Schupack D; Mendoza G; McCright-Gill T; Dellon ES; Hirano I; Alexander J; Chehade M; Safroneeva E; Bussmann C; Biedermann L; Schreiner P; Schoepfer AM; Straumann A; Katzka DA
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2514-2523.e2. PubMed ID: 32798703
[TBL] [Abstract][Full Text] [Related]
2. Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients.
Greuter T; Safroneeva E; Bussmann C; Biedermann L; Vavricka SR; Katzka DA; Schoepfer AM; Straumann A
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):419-428.e6. PubMed ID: 29902648
[TBL] [Abstract][Full Text] [Related]
3. Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis.
Bon L; Safroneeva E; Bussmann C; Biedermann L; Schreiner P; Vavricka SR; Schoepfer AM; McCright-Gill T; Simon HU; Straumann A; Chehade M; Greuter T
United European Gastroenterol J; 2022 Apr; 10(3):308-318. PubMed ID: 35384368
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.
Greuter T; Alexander JA; Straumann A; Katzka DA
Clin Transl Gastroenterol; 2018 Dec; 9(12):e212. PubMed ID: 30802222
[TBL] [Abstract][Full Text] [Related]
5. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
Eur J Pediatr; 2024 May; ():. PubMed ID: 38819501
[TBL] [Abstract][Full Text] [Related]
6. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
7. Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study.
Bredenoord AJ; Dellon ES; Hirano I; Lucendo AJ; Schlag C; Sun X; Glotfelty L; Mannent L; Maloney J; Laws E; Mortensen E; Shabbir A
Gut; 2024 Feb; 73(3):398-406. PubMed ID: 38050037
[TBL] [Abstract][Full Text] [Related]
8. Recent insights on the use of topical steroids in eosinophilic esophagitis.
Reddy A; Ashat D; Murali AR
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept.
Greuter T; Bussmann C; Safroneeva E; Schoepfer AM; Biedermann L; Vavricka SR; Straumann A
Am J Gastroenterol; 2017 Oct; 112(10):1527-1535. PubMed ID: 28719593
[TBL] [Abstract][Full Text] [Related]
10. Elimination Diet or Swallowed Topical Steroid Treatment of Pediatric Eosinophilic Esophagitis: Five-Year Outcomes.
Nistel M; Andrews R; Furuta GT; Atkins D
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2516-2523.e2. PubMed ID: 37263351
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
[TBL] [Abstract][Full Text] [Related]
12. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
[TBL] [Abstract][Full Text] [Related]
13. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.
Nennstiel S; Schlag C
World J Gastroenterol; 2020 Sep; 26(36):5395-5407. PubMed ID: 33024392
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
von Arnim U; Malfertheiner P
Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
[TBL] [Abstract][Full Text] [Related]
15. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
16. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
Kuchen T; Straumann A; Safroneeva E; Romero Y; Bussmann C; Vavricka S; Netzer P; Reinhard A; Portmann S; Schoepfer AM
Allergy; 2014 Sep; 69(9):1248-54. PubMed ID: 24894658
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice.
Laserna-Mendieta EJ; Casabona S; Savarino E; Perelló A; Pérez-Martínez I; Guagnozzi D; Barrio J; Guardiola A; Asensio T; de la Riva S; Ruiz-Ponce M; Rodríguez-Oballe JA; Santander C; Arias Á; Lucendo AJ;
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2903-2911.e4. PubMed ID: 31988045
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician.
Feo-Ortega S; Lucendo AJ
Therap Adv Gastroenterol; 2022; 15():17562848211068665. PubMed ID: 35069803
[TBL] [Abstract][Full Text] [Related]
19. Variability in Swallowed Topical Corticosteroid Practice Patterns for Treatment of Pediatric Eosinophilic Esophagitis.
Syverson EP; Tobin M; Patton T; Franciosi JP; Gupta SK; Venkatesh RD
J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):256-259. PubMed ID: 37204839
[TBL] [Abstract][Full Text] [Related]
20. Older patients with eosinophilic esophagitis have high treatment response to topical steroids.
Ketchem CJ; Thakkar KP; Xue A; Reddy S; Abramson L; Greenberg SB; Abichandani S; Miller TL; Chang NC; Eluri S; Reed CC; Dellon ES
Dig Liver Dis; 2022 Apr; 54(4):477-482. PubMed ID: 34789398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
